Article

Investigating the role of the PD-1 pathway in human ovarian cancer

2010-01-01

Abstract excerpt

Tumours have been shown to have a number of mechanisms to suppress immunosurveillance allowing them to survive and grow. One of these mechanisms involves expression of molecules which inhibit T cells such as the molecules involved in the PD-1 pathway. PD-1 is expressed on activated T cells and one of its ligands, PD-L1 has been shown to be expressed on a wide range of cell types including antigen presenting cells...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 394e5b9d-f668-555d-9d9f-c475fd51115c
DOI: 10.25560/5578

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest

Investigating the role of the PD-1 pathway in human ovarian cancerDOI 10.25560/5578Read

Study of immunomics and immune regulation in ovarian cancerSemantic proximity Read

Expression and T cell Regulatory Action of the PD-1 Immune Checkpoint in the Ovary and Fallopian TubeSemantic proximity Read

PD-1/PD-L1 expression in mutated ovarian cancersSemantic proximity Read

Short term inhibition of immune checkpoint proteins increases ex vivo expansion of tumour infiltrating lymphocytes in high grade serous ovarian cancerSemantic proximity Read

Influence of ovarian cancer type I and type II microenvironment on the phenotype and function of monocyte-derived dendritic cells.Semantic proximity Read

Phenotype of lymphocyte in ovarian tumor peritoneal fluid. A preliminary study.Semantic proximity Read

Modulation of p38 MAPK signaling enhances dendritic cell activation of human CD4+ Th17 responses to ovarian tumor antigen.Semantic proximity Read

Tumor-associated macrophages mediate immune suppression by secreting PD-L1+ exosomes in epithelial ovarian cancerSemantic proximity Read